Frederick Lang, Jr

Title: Innovations of Frederick Lang, Jr.

Introduction

Frederick Lang, Jr. is a notable inventor based in Houston, TX, who has made significant contributions to the field of cancer therapy. With a total of four patents to his name, Lang's work focuses on the development of biomarkers and combination therapies that utilize oncolytic viruses and immunomodulation.

Latest Patents

Lang's latest patents revolve around the identification of biomarkers that are useful for prognosis, selection, and monitoring of oncolytic virus therapy in cancer patients. His inventions provide a method for identifying proteins whose expression patterns can predict the outcome of oncolytic virus therapy. This innovation is particularly valuable for selecting cancer patients who may be non-responsive to such therapies. By co-administering agents that stimulate a cell-mediated immune response alongside the oncolytic virus, or by offering alternative therapies, Lang's work aims to enhance treatment efficacy for various types of cancer.

Career Highlights

Throughout his career, Frederick Lang, Jr. has worked with prominent organizations, including the University of Texas System and Dnatrix, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field, further advancing his research and innovations.

Collaborations

Lang has collaborated with notable colleagues such as Candelaria Gomez-Manzano and Charles A Conrad. These partnerships have contributed to the development of his groundbreaking work in cancer therapy.

Conclusion

Frederick Lang, Jr. is a distinguished inventor whose contributions to cancer treatment through innovative therapies and biomarkers have the potential to significantly impact patient outcomes. His ongoing research continues to pave the way for advancements in the medical field.